Navigation Links
Jazz Pharmaceuticals Reports Full Year And Fourth Quarter 2012 Financial Results
Date:2/26/2013

ion, during the fourth quarter of 2012, the company sold its women's health business for $97.6 million and recorded a non-recurring gain of $35.2 million.  Financial results from the women's health business are reported as discontinued operations for all periods presented.

2013 Financial GuidanceJazz Pharmaceuticals is providing the following 2013 guidance:

 Revenues

 

$805-$835 million

 Total Net Product Sales

 

$798-$827 million

 -Xyrem Net Sales

-Erwinaze/Erwinase Net Sales

$530-$540 million

$155-$165 millionAdjusted Gross Margin %1,3

87-89%Adjusted Combined SG&A and R&D Expenses2,3

 

$260-$275 million 

GAAP Net Income Per Diluted Share

$3.17-$3.47Adjusted Net Income Per Diluted Share3

$5.70-$5.90 

1.

Excludes $4 million of acquisition accounting inventory fair value step-up and $2 million in share-based compensation expense from estimated GAAP gross margin of 86-88%.2.

Excludes $46-$48 million of share-based compensation expense, $15 million related to a change in fair value of contingent consideration, $4 million of depreciation expense and $1-2 million of transaction, integration and restructuring costs from estimated GAAP combined SG&A and R&D expenses of $325-$340 million.3.

See "Non‑GAAP Financial Measures" below.  A reconciliation of non-GAAP adjusted guidance measures shown above is included with this press release.Conference Call DetailsJazz Pharmaceuticals will host an investor conference call and live audio webcast today at 4:30 p.m. EST (9:30 p.m. GMT) to provide a business and financial update and discuss 2012 full year and fourth quarter results and 2013 financial guidance.  The live webcast may be accessed from the Investors & Media section of the company's we
'/>"/>

SOURCE Jazz Pharmaceuticals plc
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
2. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
3. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
4. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
5. Icahn Issues Statement Regarding Amylin Pharmaceuticals
6. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
7. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
8. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
9. Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results Conference Call On May 8, 2012
10. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
11. Avanir Pharmaceuticals To Present at Three Conferences In May
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2014)... , Nov. 28, 2014 Alimera Sciences, ... pharmaceutical company that specializes in the research, development ... into a Securities Purchase Agreement with Deerfield Management ... which Alimera will issue shares of preferred stock ... approximately $50.0 million upon the satisfaction of certain ...
(Date:11/27/2014)... , Nov. 27, 2014 - ... Academic Research - JIN Co., Ltd. will launch ... market price of 500,000 yen or $5,000 (without tax /including ... The "ACADEMIC PACK" is a dedicated solution of "JINS MEME" ... and analyze deep data* generated by electrooculography and six-axis sensors ...
(Date:11/26/2014)... Nov. 26, 2014  Cohen, Placitella & Roth, ... investors who purchased Nymox Pharmaceutical Corporation ("Nymox" or ... period from January 31, 2011 through November 2, ... and certain of its officers and directors publically ... of Sections 10(b) and 20(a) of the Securities ...
Breaking Medicine Technology:Alimera Sciences Announces Agreement with Deerfield Management for $50.0 Million Financing 2Alimera Sciences Announces Agreement with Deerfield Management for $50.0 Million Financing 3JIN to Launch JINS MEME ACADEMIC PACK in Late April 2015 2JIN to Launch JINS MEME ACADEMIC PACK in Late April 2015 3Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation for Failing to Disclose Material Information 2Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation for Failing to Disclose Material Information 3
... 15, 2007 - SIGA Technologies, Inc.,(NASDAQ: SIGA) announced ... guinea pig trial of its lead Lassa fever ... Level 4 conditions at,the U.S. Army Medical Research ... under the supervision of Dr.,Mary Guttieri, who has ...
... broad range of clinical data on leading,drug-eluting stent ... Boston,Scientific Corporation today announced the schedule of the,Company's ... Paris,Course on Revascularization (EuroPCR), which will runs from ... will be announcing new data from several of ...
Cached Medicine Technology:SIGA Passes First Hurdle with Lassa Fever Antiviral ST-193 2SIGA Passes First Hurdle with Lassa Fever Antiviral ST-193 3SIGA Passes First Hurdle with Lassa Fever Antiviral ST-193 4Boston Scientific Announces Schedule for EuroPcr 2007 2Boston Scientific Announces Schedule for EuroPcr 2007 3Boston Scientific Announces Schedule for EuroPcr 2007 4Boston Scientific Announces Schedule for EuroPcr 2007 5
(Date:11/28/2014)... Angeles, CA (PRWEB) November 28, 2014 ... online, reported during the hugely popular, 2014 ... the antismoking organization Truth launched ground-breaking celebrity centered ... 18-49. The MTV viewership figures were estimated by ... Truth antismoking ads placed the spotlight on celebrities ...
(Date:11/28/2014)... November 28, 2014 A newly released ... an overview of the influenza virus that will soon be ... , The article begins with a brief explanation of ... symptoms. It reminds families that children under the age of ... from chronic diseases, such as heart and lung diseases, asthma, ...
(Date:11/28/2014)... Patten Pecans, based in Lakeland, Georgia, loves ... driving them, they've added a pecan oil to their ... oils, they've found this pecan oil from Oliver ... retaining the buttery pecan notes that are in the ... found in pecans nuts is found in pecan oil, ...
(Date:11/28/2014)... Schools like Centra Rivermont understand the therapeutic ... equipment to its students. That is why the ... play structure at its mental health services facility ... programs for children who are identified as needing ... have served the needs of children with severe ...
(Date:11/28/2014)... talklocal ( http://www.talklocal.com ) is launching in Denver, ... phone in about 90 seconds. , The launch comes ... to have touched down just north of the city on ... Denver residents now know all too well the value of ... local pros in over 50 service categories on speed dial ...
Breaking Medicine News(10 mins):Health News:Freedom Laser Therapy Applauds American Legacy’s Creative Advertising Targeting Celebrity Smokers 2Health News:Freedom Laser Therapy Applauds American Legacy’s Creative Advertising Targeting Celebrity Smokers 3Health News:Freedom Laser Therapy Applauds American Legacy’s Creative Advertising Targeting Celebrity Smokers 4Health News:Freedom Laser Therapy Applauds American Legacy’s Creative Advertising Targeting Celebrity Smokers 5Health News:How Flu Vaccines Can Impact Families Is Discussed in New Article from Community Health Center of Snohomish County 2Health News:Patten Pecans Goes Local with Nutritious Georgia Pecan Oil 2Health News:Centra Rivermont (VA) Provides School Playground Equipment from APCPLAY© for Special Needs Students 2Health News:Centra Rivermont (VA) Provides School Playground Equipment from APCPLAY© for Special Needs Students 3Health News:TalkLocal Launches In Denver A Week After Multiple Tornadoes Hit Near City 2
... have now found that it is helpful in delaying the effects ... ... Manhasset, NY (Vocus) May 6, 2009 -- Nicotine has ... is helpful in delaying the effects of ricin, the toxic substance ...
... The Swine Flu/H1N1 Virus can be contained and controlled by ... which has proven to be 100% effective against Type A ... conjunction with the U.S. Military to neutralize weapons of mass ... bacterial substances. MDF200 can neutralize a contaminated structure in ...
... Perrigo Company (Nasdaq: PRGO ; TASE) ... quarterly dividend of $0.055 per share, payable on June ... 2009. Perrigo Company is a leading global healthcare supplier ... prescription pharmaceuticals, nutritional products, active pharmaceutical ingredients (API) and ...
... know their blood lactate level. It indicates how much ... result of physical exertion and enables conclusions to be ... to attend performance diagnosis sessions. As they pedal a ... takes blood samples from an earlobe. A special device ...
... for Earth Day Network PHOENIX, May 6 ... Sadowski has won the PurexSavesGreen tote bag design contest, ... slogan and funky leaf design took the top prize ... from all 50 states. Mr. Sadowski will receive a ...
... American Cancer Society in providing services to newly ... WellPoint Foundation, LLC, a private, non-profit organization wholly ... in the total amount of $1 million to ... of its Hope Lodge network and Patient Navigation ...
Cached Medicine News:Health News:Nicotine May Help Prevent Damage from Bioterrosim Toxin and Growth Factors in Heart Disease News from Molecular Medicine 2Health News:Swine Flu/H1N1 Contained With Emergency Restoration and MDF200 2Health News:Lactate test made easy 2Health News:Photo: Wisconsin Artist Wins Purex Saves Green Tote Bag Design Contest 2Health News:Photo: Wisconsin Artist Wins Purex Saves Green Tote Bag Design Contest 3Health News:Photo: Wisconsin Artist Wins Purex Saves Green Tote Bag Design Contest 4Health News:American Cancer Society Awarded Dual WellPoint Foundation Grants to Expand Hope Lodge Network and Patient Navigation Program 2Health News:American Cancer Society Awarded Dual WellPoint Foundation Grants to Expand Hope Lodge Network and Patient Navigation Program 3Health News:American Cancer Society Awarded Dual WellPoint Foundation Grants to Expand Hope Lodge Network and Patient Navigation Program 4
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: